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Abstract 35 
Ageing is associated with re-modelling of the immune system to enable the maintenance of 36 
life-long immunity. In the CD8+ T cell compartment, ageing results in the expansion of highly-37 
differentiated cells that exhibit characteristics of cellular senescence. Here we found that 38 
CD27-CD28-CD8+ T lost the signalling activity of the T cell antigen receptor (TCR) and 39 
expressed a protein complex containing the agonistic NK receptor NKG2D and the NK adaptor 40 
molecule DAP12, which promoted cytotoxicity against cells that expressed NKG2D ligands. 41 
Immunoprecipitation and imaging cytometry indicated that the NKG2D-DAP12 complex was 42 
associated with sestrin 2. The genetic inhibition of sestrin 2 resulted in decreased expression 43 
of NKG2D and DAP12 and restored TCR signaling in senescent-like CD27-CD28-CD8+ T cells. 44 
Therefore, during ageing, sestrins induces the reprogramming of non-proliferative senescent-45 
like CD27-CD28-CD8+ T cells to acquire a broad-spectrum, innate-like killing activity.  46 
  47 
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Immunity declines during ageing and this is associated with an increased incidence of 48 
infections and malignancy1. It is therefore essential to understand mechanisms that contribute 49 
to altered immunity in older individuals in order to identify possible therapeutic targets. 50 
Because the thymus involutes from puberty onwards, its contribution to the maintenance of 51 
the T cell pool decreases considerably during ageing. Instead, antigen specific T cells are 52 
maintained in older individuals by repeated episodes of activation and proliferation triggered 53 
by specific or cross-reactive antigenic challenge or by homeostatic cytokines2. This extensive 54 
proliferative activity leads ultimately to extreme functional differentiation and the development 55 
of T cell senescence associated with telomere erosion, decreased signalling through the T cell 56 
antigen receptor (TCR), activation of the telomere-extending enzyme telomerase and growth 57 
arrest3-5. Because the replicative activity of T cells is impaired as senescence develops, 58 
mechanisms other that T cell proliferation may be required to maintain optimal immune 59 
protection during ageing.  60 
Highly-differentiated CD8+ T cells that lose expression of the surface receptors CD28 and 61 
CD27 (CD27-CD28-) exhibit senescent-like characteristics that include low proliferative 62 
activity, short telomeres, low telomerase activity and expression of senescence-associated 63 
cell surface (CD57 and KLRG1) and intracellular (the MAP kinase p38, γH2AX) molecules4. 64 
CD27-CD28-CD8+ T cells also upregulate receptors associated with natural killer (NK) cells, 65 
such as inhibitory (KLRG1, NKG2A) and activatory proteins (NKG2C and NKG2D)6. Whether 66 
the acquisition of the senescence-like characteristics and the expression of NK receptors 67 
(NKR) are linked or are controlled independently remains unclear. 68 
Sestrins are stress-sensing proteins, induced by conditions of low glucose or oxidative stress 69 
or cellular senescence, that inhibit TCR activation and CD4+ T cell proliferation in both mice 70 
and humans7. Here we showed that sestrins inhibited the expression of the TCR signaling 71 
molecules LAT, ZAP70 and LCK in mouse and human CD8+ T cells, and concomitantly 72 
induced the expression of both inhibitory and activatory NKRs. Furthermore, sestrins 73 
regulated the association of NKG2D with the scaffold protein DAP12, which converts it into an 74 
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activating receptor that can trigger the secretion of cytokines and cytotoxicity towards target 75 
cells bearing NKG2D ligands, independently of the TCR. Collectively, these data indicated 76 
that senescent-like CD8+ T cells were not a defective end-stage population. Instead these 77 
cells, while non-proliferative, were instead re-programmed during differentiation to recognize 78 
and kill through both TCR8 as well as NKR recognition mechanisms, a process regulated by 79 
the sestrins. The repurposing of senescent-like CD8+ T cells to mediate innate-like functional 80 
activity may be crucial to mitigate against the increased burden of tumours and stromal 81 
senescent cells that accumulate in tissues during ageing9,10. 82 
 83 
Results 84 
Human CD8+ TEMRA cells upregulate NKRs but decrease TCR components  85 
First, we isolated peripheral blood CD8+ T cell subsets from six healthy donors and compared 86 
the transcriptomes of CD27+CD45RA-CD8+ central memory T cells (TCM  cells), CD27-87 
CD45RA- CD8+ effector memory T cells (TEM cells) and CD27-CD45RA+CD8+ terminal effector 88 
memory T cells (TEMRA cells) relative to the CD27+CD45RA+CD8+ naïve T cells (TN cells) using 89 
Affymetrix U133 plus 2 microarrays (Fig. 1a and Extended Data Fig. 1a). Differentially 90 
expressed genes in these CD8+ T cell subsets were identified based on a minimum of a 2-fold 91 
change (p <0.05, false-discovery rate (FDR) for multiple comparisons <0.05% (Supplementary 92 
table 1). Hierarchical clustering of genes associated with effector cell function indicated a 93 
transcriptional signature that distinguished TEMRA cells from TN cells (Fig. 1b,c). Genes 94 
involved in co-stimulation (Cd28, Cd27), TCR signaling (Trac, Cd3e, Cd3g, Lck, Lat, Plcg1) 95 
and proliferation and cell cycle control (Ccne1, Ccnd3) were downregulated in TEMRA cells 96 
compared to TN cells (Fig. 1b,c). Compared to CD8+ TN cells, CD8+ TEMRA cells upregulated 97 
genes encoding the transcription factors Zeb2 (fold change: 10.75, p < 0.0001) and Zbtb16 98 
(encoding PLZF, fold change: 6.48, p < 0.0001, Fig. 1b, Supplementary Table 2) which are 99 
known to regulate terminal differentiation of memory T cells11 and the development of innate-100 
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like features in T cells in mice12,13. Zbtb16 was also increased in TCM cells and TEM cells 101 
compared to TN cells (7.7- and 4.8-fold respectively; Supplementary table 2). TEMRA cells 102 
upregulated genes encoding NKRs (including Kir family members, Nkg2a/c and Klrg1), innate 103 
signalling adaptors (Tyrobp, encoding DAP12) and molecules involved in cytotoxicity 104 
(Gzma/b, Prf, Fasl, Itgav and Itgb1)14. TEMRA cells also upregulated chemokine receptors 105 
associated with the migration of NK cells into tissues (Cx3cr1, S1pr5, and Cmklr1)15, indicating 106 
that the differentiation of CD8+ T cells from TN cells into TEMRA cells was associated with a 107 
transcriptional program that promoted cytotoxic effector functions at the expense of 108 
proliferative potential and suggested that highly-differentiated CD8+ T cells may express 109 
effector functions independent of the TCR. 110 
Flow cytometric analysis indicated that the expression of NKRs on non-NK cells was elevated 111 
on CD3+CD27-CD45RA+CD8+ TEMRA cells (Fig. 1d, Extended Data 1a) in PBMCs isolated 112 
from a separate cohort of healthy donors (n = 22; median age = 52; range = 25-83). The 113 
repertoire of NKRs expressed on CD8+ TEMRA cells was diverse and included both activating 114 
(NKG2D, NKG2C and KIR2DS) and inhibitory (NKG2A, KIR2DL/KIR3DL and CD244) 115 
receptors, as well as the maturation markers KLRG1 and CD57 (Fig. 1d, Extended Data 1b). 116 
Expression of CD28 and CD27 is sequentially lost on CD8+ T cells as they transition from 117 
CD27+CD28+ CD8+ TN cells to CD27+CD28- intermediate CD8+ T cells and to terminal, or 118 
senescent-like, CD27-CD28- CD8+ T cells16,17.  To analyse the expression of the TCR signalling 119 
machinery in CD8+ TEMRA cells, we isolated CD8+ T cell subsets by their relative expression of 120 
CD27 and CD28, as the use of CD27 and CD28 as markers enabled the isolation of more 121 
cells for functional analyses. The CD27-CD28-CD8+ T cell subset contained the TEMRA subset 122 
and TEM subset (Extended Data 1c) and had increased expression of NKRs compared to 123 
CD27+CD28+CD8+ TN cells (Extended Data 2a). Senescent-like CD8+ T cells, either identified 124 
as CD27-CD28-18,19 or as CD27-CD45RA+20 increase in both number and proportion during 125 
ageing and exhibit markers of senescence4,5,7,20. Immunoblots showed a significant 126 
downregulation of LCK, LAT and PLC-γ1, but upregulation of ZAP70 in CD27-CD28-CD8+ T 127 
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cells compared to CD8+ TN cells (Fig. 1e). CD27-CD28-CD4+ T cells also acquired cell-surface 128 
expression of NKRs (including KLRG1, NKG2C and NKG2D), but to a lower degree than 129 
CD27-CD28-CD8+ T cells (Extended Data 2b). Together, these findings indicated the 130 
increased expression of NKRs on CD8+ T cells with characteristics of terminal differentiation 131 
and senescence. 132 
Individual TEMRA CD8+ T cells are senescent and express NKRs and cytotoxic molecules 133 
To investigate whether NKRs, cytotoxicity-related molecules and senescence markers were 134 
expressed on individual CD8+ TEMRA cells, we used single cell RNA-sequencing (scRNA-seq) 135 
to investigate the transcriptomes of ~62,000 CD8+ T cells isolated from six healthy old donors 136 
(72-88 yrs). CD8+IL-7R+ and CD8+IL-7R- T cells were sorted from each donor resulting in 12 137 
samples (Extended Data 3a). Sorts yielded an average of 6199 CD8+IL-7R+ cells (SD 1582) 138 
and 4192 CD8+IL-7R- cells (SD 1269) per donor, with an average of 1043 and 1011 genes per 139 
cell, respectively (Extended Data 3b,c). After discarding hybrid transcriptomes (multiplets) 140 
using Scrublet (Methods), raw data from the 12 samples (six CD8+IL-7R+ and six CD8+IL-7R- 141 
T cells) were combined. scRNA-seq profiles that passed the quality control (Extended Data 142 
3d) were then corrected for technical batch effects (e.g. 10x run) using BBKNN. Unbiased 143 
clustering followed by a two-dimensional uniform manifold approximation and projection 144 
(UMAP) on the corrected data identified 13 distinct clusters (Fig. 2a). Cluster assignments 145 
were independent of batch (Extended Data 3e) and donor (Extended Data 3f) effects. The 146 
CD8+IL-7R+ and CD8+IL-7R+ groups associated with distinct sets of clusters (Fig. 2b). The 147 
number of cells within each cluster varied from 9,263 to 915 (Extended Data 3g) and their 148 
expression of Il7r mRNA was confirmed (Extended Data 4a). We assigned clusters to cell 149 
types based on differential analysis comparing expression values among cells from a given 150 
cluster to all other cells (Supplementary Table 3). All clusters expressed transcripts for Cd3e 151 
and Cd8, but not Cd4 (Fig. 2c). We could identify clusters of TN cells (expressing Cd27, Ccr7, 152 
Sell or Cd28) and effector T cells (expressing Klrg1, Prf1 or Gzmb) (Fig. 2c). Based on this 153 
expression profile, clusters C0, C4 and C8 were defined as CD8+ TN cells, and C1, C2 and C6 154 
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as CD8+ TEMRA cells (Fig. 3a). A second round of clustering performed on these six clusters 155 
confirmed the distinct transcriptomic profiles of the CD8+ TN and CD8+ TEMRA compartments 156 
(Fig. 3b, Extended Data 4b) and confirmed the enrichment of the CD8+TEMRA compartment 157 
within the CD8+IL-7R- cells (Extended Data 4c). CD8+ TN cells were characterized by the 158 
expression of Cd27, Cd28, Ccr7 and Sell, while CD8+ TEMRA cells showed an upregulation of 159 
Klrg1, Prf1 or Gzmb relative to the clusters of CD8+ TN cells (Extended Data 4d). 160 
The expression of 15 NK-associated genes, including Fcgr3a (encoding the Fcγ receptor 161 
CD16), the NK-related receptors Fcrl6, Klrc1 and -2, Klrg1 and Tyrobp (Fig. 3c) was used to 162 
define an “NK score”. This confirmed that CD8+ TEMRA cells become NK-like compared to CD8+ 163 
TN cells (Fig. 3d; Supplementary Table 4). Similarly, we used expression of senescence-164 
related genes, such as B3gat1 (encoding the enzyme that creates the CD57 epitope), the cell 165 
cycle regulators Cdkn1a and Cdkn2a, and sMAC components such as Sesn2 and Mapk1 to 166 
create a “senescence score” to determine whether CD8+ TEMRA cell were senescent compared 167 
to CD8+ TN cells (Fig. 3e,f, Supplementary Table 4). Although expression of LCK, PLC-γ1 and 168 
LAT proteins was decreased in CD27-CD28-CD8+ T cells compared to TN CD8+ cells (Fig. 1e), 169 
the mRNA for these TCR signalling components was similar in CD8+ TEMRA and CD8+ TN cells 170 
analysed by scRNA-seq (not shown), suggesting their expression might be regulated by post-171 
translational modification in CD27-CD28-CD8+ T cells. These observations suggested that 172 
CD8+ TEMRA cells had characteristics of cellular senescence and expressed a range of NKRs, 173 
NK adaptors and cytotoxic mediators.  174 
NKG2D and DAP12 induce cytotoxicity in senescent CD8+ T cells  175 
We next investigated whether CD27-CD28-CD8+ T cells had NK cell-like functions 176 
independently of TCR-MHC interactions. Based on the expression of the degranulation marker 177 
CD107a21, CD27-CD28-CD8+ T cells killed K562 cells, an MHC class I-deficient tumour cell 178 
line, with the same efficiency as NK cells (Fig. 4a). These data were confirmed using a calcein-179 
release assay (Extended Data 5a,b). To address whether NKG2D mediated the cytotoxic 180 
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activity of CD27-CD28-CD8+ T cells, we knocked down NKG2D in CD28-CD8+ T cells with a 181 
small interfering RNA (siRNA) specific for NKG2D (siNKG2D CD8+T cells) and assessed their 182 
ability to kill MHC class I-deficient C1R cells transfected with the NKG2D ligand MICA*008 183 
(C1R-MICA cells) when co-cultured for 6 hours (Extended Data 5c,d). CD28-CD8+T cells 184 
transfected with scrambled siRNA (siCtrl) showed increased degranulation, measured by 185 
CD107a exposure, towards C1R-MICA compared to C1R cells, while the cytotoxicity of 186 
siNKG2D CD8+ T cells towards the C1R-MICA cells was inhibited compared to siCtrl (Fig. 4b), 187 
indicating that CD28-CD8+ T cells could kill target cells in a manner dependent on NKG2D. 188 
Expression of NKG2D on the cell surface requires its association with adaptor proteins that 189 
stabilise the immunoreceptor complex and provide it with signalling activity22. NKG2D 190 
associates with the adaptor molecules DAP10 and DAP12. DAP10 contains an YxxM-motif 191 
that activates PI3K23,24, while DAP12 has an ITAM-motif that can recruit and activate ZAP70-192 
Syk triggering cytokine release and cytotoxicity25-27. In human CD8+ T cells, NKG2D is 193 
predominantly associated with DAP1023,27 (Extended Data 5e), which allows it to act as a co-194 
stimulatory signal for the TCR. Immunoblot analysis (Fig. 4c) and intracellular flow cytometry 195 
(Fig. 4d) indicated increased expression of DAP12 in CD27-CD28-CD8+ T cells compared to 196 
CD8+ TN cells, corresponding to the transcriptomic data indicating that Tyrobp (which encodes 197 
DAP12) was strongly induced in CD8+ TEMRA cells compared to CD8+ TN cells. To investigate 198 
whether the killing activity of CD27-CD28-CD8+ T cells was mediated by DAP12 association 199 
with NKG2D, we immunoprecipitated NKG2D from CD28+CD8+ or CD28-CD8+ T cells isolated 200 
from peripheral blood of healthy donors. DAP12 associated with NKG2D only in the CD28-201 
CD8+ T cells (Fig. 4e). 202 
We next investigated whether ligation of NKG2D induced the phosphorylation of ZAP70-Syk 203 
in CD27-CD28-CD8+ T cells. CD3 ligation with a  monoclonal antibody (mAb) against CD3 204 
induced the phosphorylation of ZAP70-Syk, as expected, while using an NKG2D mAb alone 205 
induced more p-ZAP70 and p-Syk compared to a CD3 mAb alone (Fig. 4f), indicating that 206 
CD27-CD28-CD8+ T cells can be activated by both the TCR and NKG2D, but show an 207 
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increased propensity to respond to the latter. NKG2D stimulation alone was sufficient to induce 208 
expression of granzyme B and secretion of the cytokine IFN-γ in CD27-CD28-CD8+ T cells 209 
(Fig. 4g). siRNA-mediated silencing of DAP12 in CD28-CD8+ T cells impaired the cytolytic 210 
degranulation of CD28-CD8+ T cells towards C1R-MICA cells compared to scrambled siRNA 211 
control-transfected CD28-CD8+ T cells (Fig. 4h). Thus, DAP12 expression was upregulated in 212 
CD28-CD8+ T cells and was necessary and sufficient to mediate NKG2D-dependent 213 
cytotoxicity.  214 
Sestrins block TCR signalling but increase NKR in CD8+ T cells 215 
CD27-CD28-CD8+ T cells have reduced proliferative activity after TCR stimulation4,5,7. We 216 
investigated whether reduced expression of the components of the CD3-TCR complex 217 
compromised the efficiency of proximal TCR signaling. Phospho-flow cytometry indicated 218 
impaired phosphorylation of CD3ζ after stimulation with CD3 antibodies in CD27-CD28-CD8+ 219 
compared to CD27+CD28+CD8+ T cells (Fig. 5a). Although the expression of total ZAP70 was 220 
increased in CD28-CD27-CD8+ T cells (Fig. 1e), its phosphorylation was impaired in these 221 
cells compared to CD28+CD27+CD8+ T cells following CD3 activation (Fig. 5b).  222 
The stress-sensing proteins sestrins induce characteristics of senescence in CD4+ T cell by 223 
forming a complex with the kinase AMPK and the MAP kinases that is inhibitory for signalling 224 
through the TCR7. Flow cytometry (Fig. 5c,d) and immunoblotting (Fig. 5e) indicated that 225 
human peripheral blood CD27-CD28-CD8+ T cells from young subjects (<40 yrs) exhibited 226 
increased expression of sestrin 1 and sestrin 2 compared to CD27+CD28+CD8+ T cells. Sestrin 227 
2 was upregulated in total CD8+ T cells from donors older than 65 years compared to those 228 
between 18-35 years (Extended Data 5f). In addition, CD27-CD28-CD8+ T cells had increased 229 
amounts of activated Jnk MAP kinase (p-Jnk) compared to CD27+CD28+CD8+ T cells (Fig. 230 
5e).  Immunoprecipitation experiments indicated that DAP12, sestrin 2 and Jnk were 231 
associated with NKG2D in CD27-CD28-CD8+ T cells (Fig. 6a), while imaging cytometry 232 
indicated that sestrin 2, DAP12 and p-Jnk co-localised in CD27-CD28-CD8+ T cells, but not in 233 
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CD8+ TN cells (Fig. 6b,c). These observations suggested that sestrin 2 associated with 234 
NKG2D-DAP12-Jnk in CD27-CD28-CD8+ cells. 235 
Next, we tested whether sestrins regulated the expression of NKG2D in human CD28-CD8+ T 236 
cells. Peripheral blood CD28-CD8+ T cells isolated from healthy donors (median age = 39; 237 
range = 25-70) were lentivirally transduced with shRNA against sestrin 1, 2 and 3 (shSesn) 238 
had significantly reduced expression of DAP12 (Fig. 6d) and NKG2D compared to CD28-CD8+ 239 
T cells transduced with control vectors (Fig. 6e), indicating sestrins modulated the expression 240 
of NKG2D in these cells. siRNA-mediated depletion of Jnk (Fig. 6f) or its inhibition with the 241 
small molecule inhibitor SP-600125 in CD28-CD8+ T cells (Fig. 6g) reduced the expression of 242 
NKG2D, increased the frequency of CD28+ cells and restored proximal TCR signalling 243 
following CD3 ligation compared to untreated CD28-CD8+ T cells (Fig. 6f,g). This indicated a 244 
reconstitution of T cell-related functions, implying sestrins may act through Jnk to induce 245 
expression of NKG2D expression in CD28-CD8+ T cells. 246 
 247 
YFV induces the upregulation of NKR on CD8+ T cells 248 
Next we tested if the upregulation of NKRs by CD8+ T cells occurred exclusively as a result of 249 
cellular senescence or if NKRs were expressed on less-differentiated subsets of CD8+ T cells 250 
in response to antigenic stimulation, and the expression was maintained as cells differentiated 251 
towards senescence. Using publicly available RNA-seq gene expression data generated in a 252 
cohort of 12 individuals vaccinated against yellow fever28, we compared CD8+ T effector (TE 253 
cells), defined as CD8+ YFV-tet+ cells that were present  at day 14 post-vaccine, and CD8+ T 254 
memory (TM cells) defined as CD8+ YFV-tet+ cells that were present 4-13 years post-vaccine, 255 
to YFV-tet- CD8+ TN cells. Cytotoxic mediators such as Fasl, Prf1, Gzma and Gzmb were highly 256 
expressed in CD8+ TE cells and CD8+ TM cells compared to CD8+ TN T cells (Extended Data 257 
6). Additionally, there was a significant upregulation of multiple NKRs, including many of the 258 
Kir, Fcgr3a, Cd57 and Klrc1 on CD8+ TE cells and CD8+ TM cells compared to CD8+ TN cells, as 259 
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well as chemokine receptors (S1pr5, Cmklr1 and Cx3cr1) and NK adaptor proteins such as 260 
Tyrobp (Extended Data 6). The upregulation of these molecules occurred on YFV-tet+CD8+ 261 
TE cells during the effector phase of the response and was maintained in long-lived YFV-tet+ 262 
TM cells (Extended data 6). Based on published data, YFV‐tet+ TM cells lack markers of 263 
senescence like CD57, are CD27+CD28+ and are polyfunctional with regard to cytokine 264 
secretion29. Unlike the CD8+ TEMRA cells, YFV‐tet+CD8+ TM cells exhibit proliferative potential 265 
in vitro, suggesting that they are not terminally differentiated29. YFV-tet+CD8+ TE and TM cells 266 
showed slight downregulation of the TCR signalosome (Lat, Plcg1, Zap70) compared to CD8+ 267 
TN cells (Extended Data 6).  Of note, sestrin 2 was upregulated in the YFV-tet+CD8+ TE and 268 
TM cells compared to CD8+ TN cells (Extended data 6). This analysis indicated that the 269 
expression of NKR on CD8+ T cells was not limited to senescent CD27-CD28-CD8 T cells but 270 
was also a feature of YFV-tet+CD8+ TE and TM cells after activation in vivo. 271 
 272 
Sestrins regulate the function of CD8+ T cells in vivo 273 
Sestrins regulate the decreased function of CD4+ T cells in aged mice and humans7. We next 274 
investigated if sestrins directly regulated the expression of NKRs in CD8+ T cells in young (~6 275 
weeks) and old (~18 months) wild-type mice and old (~18 months) Sesn1-/- and Sesn2-/- mice. 276 
Mice were vaccinated subcutaneously against methylated BSA (mBSA) and re-challenged 277 
with mBSA in the footpad two weeks later to induce a delayed-type hypersensitivity (DTH) 278 
response as an index of successful immune induction. All mice mounted a DTH response to 279 
the re-challenge, but the DTH response in old wild-type, Sesn1-/- and Sesn2-/- mice resulted in 280 
increased footpad swelling compared to young wild-type mice (Fig. 7a). The response 281 
resolved more slowly in old wild-type compared to young wild-type mice, while old Sesn1-/- 282 
and Sesn2-/- mice resolved faster than old wild-type mice (Fig. 7a,b). Spleen weights were 283 
equivalent in all groups post-mBSA challenge (Extended Data 7a). There were no changes 284 
in the proportions of splenic NK cells, iNKT cells, CD4+ T cells and CD8+ T cells in all old and 285 
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young mice following the DTH response (Extended Data 7b,c). However, CD44+CD62L-CD8+ 286 
T effector cells (TEFF cells) expanded, while CD44-CD62L+CD8+ TN cells decreased in old wild-287 
type mice, but not in old Sesn1-/- and Sesn2-/- mice, compared to young wild-type mice 288 
(Extended Data 7d,e). 289 
Expression of NKG2D and DAP12, as well as NKG2A, NKG2C, NKG2E and Ly49 was higher 290 
on the CD8+ T cells from the old wild-type mice compared to young wild-type mice, whereas 291 
their expression was lower in old Sesn1-/- and Sesn2-/- mice compared to old wild-type mice 292 
(Fig. 7c-e and Extended Data Fig. 7f), suggesting the expression of these receptors was 293 
modulated by sestrins. Importantly, the expression of NKG2D, as well as NKG2A, NKG2C, 294 
NKG2E on CD3-TCRβ-NK1.1+ NK cells or TCRβ+CD1d-tet+ iNKT cells was similar in young 295 
wild-type, old wild-type and old Sesn1-/- and Sesn2-/- mice (Fig. 7f), indicating that sestrins 296 
uniquely regulated the expression of NKRs in CD8+ T cells. To examine the effect of sestrin 297 
deficiency on the cytotoxic function of CD8+ T cells in vivo, 24-month old wild-type mice and 298 
24-month old Sesn1-/-Sesn2-/-Sesn3+/- mice were depleted of NK cells by intra-peritoneal 299 
treatment with an NK1.1 Ab prior to intra-venous injection of equal numbers of 5tgm1 myeloma 300 
cells expressing Rae-1, the mouse equivalent of MICA/B, and Rae-1- splenocytes. Six hours 301 
post-transfer of target cells, more Rae-1+ 5TGM1 cells were detected in the spleens of Sesn1-302 
/-Sesn2-/-Sesn3+/- mice compared to wild-type mice (Fig. 7h). This resulted from decreased 303 
specific lysis of Rae-1+ 5TGM1 target cells in Sesn1-/-Sesn2-/-Sesn3+/- mice compared to wild-304 
type mice (Fig. 7h). These observations indicated that the sestrins regulated the expression 305 
of NKG2D and DAP12 and conferred NK cell-like cytotoxic activity to CD8+ T cells of old mice 306 
in vivo. 307 
 308 
Discussion 309 
Here we provide phenotypic, functional and mechanistic data to indicate that as CD8+ T cells 310 
differentiated towards senescence they lost the expression of co-stimulatory molecules such 311 
as CD28 and CD27 and downregulated TCR signalling molecules such as Lck and LAT, while 312 
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upregulating the expression of NKRs such as NKG2D, NKG2A and CD16. Compared to 313 
CD28+CD27+CD8+ T cells, CD28-CD27-CD8+ T cells acquired a senescent phenotype. 314 
Expression of NKRs was associated with acquisition of the ability to kill tumour cells in vitro 315 
and in vivo through an NKR-dependent process. The downregulation of TCR-related signalling 316 
molecules concomitantly with the acquisition of NKR-related molecules was regulated by 317 
sestrins.  318 
 319 
Altered TCR signalling pathways in iNKT and antigen-specific CD8+ T cells result in the 320 
development of unconventional functions that are not restricted to TCR-MHC interactions30,31. 321 
The suppression of TCR signalling, along with an acquired responsiveness to innate stimuli 322 
was proposed to be a characteristic that defines innate-like T cells32. Here, we found that the 323 
TCR to NKR functional switch in CD8+ T cells was dependent on the kinase Jnk, similar to 324 
previous findings in CD4+ T cells7. The mechanism by which sestrins modulate this transition 325 
remains unclear. Experiments in sestrin-deficient mice indicated that sestrins did not regulate 326 
the expression of NKRs in NK cells or iNKT cells, and it remains unclear if sestrins may 327 
regulate the function of other types of innate-like T cells e.g. γδ T cells. 328 
 329 
The reprogramming of CD27-CD28-CD8+ T cells from TCR to NKR functional activity could be 330 
particularly relevant for CD8+ T cells specific for persistent pathogens, such as 331 
cytomegalovirus (CMV) and Epstein-Barr virus (EBV), which accumulate during ageing33-35. 332 
Our data suggest that in addition to their role in maintaining long-term specific immunity 333 
against these viruses, these cells may also recognize virus-infected cells or tumour cells 334 
through an NK cell-like, antigen-independent manner, thus enabling them to exhibit broad 335 
protective functions.  336 
 337 
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Our observations raise questions about the biological significance of such changes and the 338 
possible advantage of generating T cells with NK cell-like characteristics. The accumulation 339 
of CD8+ TEMRA cells was reported to be a predictor of successful ageing8. One reason for this 340 
may be that acquisition of NKRs by CD8+ TEMRA cells might allow them to broaden their 341 
capacity for immune surveillance by utilising different recognition systems, thereby partly 342 
compensating for decreased output of TN cells in older subjects and reduced TCR-mediated 343 
classical T cell function36. Given the increased burden of tumours and infections with age, the 344 
expansion of NK cell-like functions in CD8+ T cells could be an advantageous adaptation that 345 
would enable the recognition of transformed cells. 346 
 347 
Senescent cells are pro-inflammatory and increase in number in many tissues during 348 
ageing37,38. The removal of these senescent tissue cells enhances organ function and retards 349 
age-related functional decline39,40.  Because NK cells and CD8+ T cells can recognize and kill 350 
senescent cells via NKG2D mediated mechanisms9,10,41, NKR-expressing CD27-CD28-CD8+ 351 
T cells may participate in the surveillance and elimination of senescent tissue cells. Based on 352 
the observations here that sestrins regulate functional fate decisions in T cells, it will be 353 
important to identify if these molecules also have similar roles in other cell types. 354 
 355 
It is important to know when the expression of sestrins and NKRs are induced on T cells after 356 
vaccination. Gene expression studies in YFV-specific CD8+ T cells from previously non-357 
immunized young individuals (<40 years) vaccinated with the yellow fever virus vaccine 358 
showed that expression of NKRs and sestrins was upregulated in the effector phase of the 359 
response (2 weeks post-vaccination) and maintained in the CD8+ TM cells for years 360 
afterwards28,29. This indicates that sestrins are not only induced when CD27-CD28-CD8+ T 361 
cells become senescent.  Naïve CD27+CD28+ T cells within the CD4 compartment of old 362 
individuals (>65 yrs) have been shown to express a significantly higher level of sestrins than 363 
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naïve CD27+CD28+CD4+ T cells from young individuals7 suggesting that this molecule will 364 
have an impact on vaccine responses, that induce the expansion of naïve T cell precursors, 365 
during ageing. It is not clear if naïve YFV-specific CD8+ T cell precursors in old humans 366 
express higher levels of sestrins and if these cells can be activated optimally after vaccination. 367 
Nevertheless, it has been shown that in old mice, sestrin inhibition can enhance the number 368 
of influenza-specific CD4+ T cells after influenza vaccination in vivo7. This may be a strategy 369 
to also enhance the response to other vaccines during ageing.  A caveat is that the long-term 370 
blockade of sestrins with either specific inhibitors or by transfection with inhibitory shRNA may 371 
be dangerous, as it could enhance the proliferation of senescent-like T cells that harbour DNA 372 
damage. However, the temporary blockade of sestrins may be a safe strategy to increase the 373 
number of antigen-specific T cells after vaccination to enhance immunity during ageing7. 374 
 375 
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Materials and Methods 412 
Study design 413 
The study protocol was approved by the Ethical Committee of the Royal Free and University 414 
College London Medical School (Research Ethics number: 11/0473). Written informed 415 
consent was obtained from all study participants. Donors did not have any co-morbidity, were 416 
not on any immunosuppressive drugs, and retained physical mobility and lifestyle 417 
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independence. For analyses involving the CD8+ T cell, IL-7R+/IL-7R- single cell dataset studies 418 
were conducted following approval by the Institutional Review Board (IRB) of the University of 419 
Connecticut Health Center (IRB 14-194J-3). After receiving informed consent, blood samples 420 
were obtained from 6 healthy old (>65 year old) research volunteers residing in the Greater 421 
Hartford, CT, region using services of the University of Connecticut Center on Aging 422 
Recruitment and Community Outreach Research Core and following previously published 423 
screening criteria (PMID:28904110). 424 
 425 
Cell isolation and transfection  426 
Peripheral blood mononuclear cells (PBMC) were isolated by density gradient (Ficoll–427 
Hypaque, Amersham Biosciences, UK) from heparinized blood of healthy donors (n = 22, 26-428 
83 years). Untouched NK and CD8+ T cells were freshly isolated by magnetic activated cell 429 
sorting (MACS, Miltenyi Biotec, UK) using a negative selection procedure. For microarray 430 
analysis, high-purity CD8+ T cell subsets were sorted on the basis of CD27 and CD45RA 431 
expression42, using a FACSAria (BD Biosciences, UK) flow cytometer. For functional assays, 432 
CD8+ T cell subsets were freshly isolated according to CD27/CD28 expression by magnetic 433 
activated cell sorting (MACS, Miltenyi Biotec, UK), which identified analogous subsets but 434 
provided higher yields of viable cells (> 95% purity) as previously described5,7. Double 435 
negative cells were obtained by complete negative isolation. We found that <1% of cells within 436 
these isolated populations expressed iNKT markers. Mucosal associated invariant T cells 437 
(MAIT) cells express TCR Vα7.2 and these cells constitute ~5% of the peripheral CD8+ T cells 438 
pool in humans43. We found 4% (range 1-7.5%) of these cells in isolated CD28+ CD27+, 3% 439 
(range 1-6.4) in the isolated CD28-CD28+ and 2.9% (range 1-4.9%) in the isolated CD28-CD27- 440 
CD8+ T cells populations. The results obtained are therefore unlikely to be due to 441 
contaminating iNKT or MAIT cells in our CD8+ T cells populations. 442 
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Where indicated, freshly purified human CD8+ T cells were transfected with small interfering 443 
RNA (siRNA) for NKG2D (Santa Cruz Biotechnology, sc-42948) or DAP12 (sc-35172) by 444 
electroporation using the Amaxa Human NK Cell Nucleofector Kit and Nucleofector 445 
technology (Lonza), according to the manufacturer’s instructions. A scrambled control siRNA 446 
(sc-37007; Santa Cruz) was used throughout. Efficiency of siRNA transfection was confirmed 447 
by measuring the expression of the protein of interest using flow cytometry, 36-48 hours after 448 
transfection. 449 
Microarray data acquisition 450 
Cells purified by FACS were stimulated for 2 hours with 0.5 µg/ml plate-coated anti-CD3 451 
(OKT3) and 5 ng/ml rhIL-2 before RNA isolation using the ARCTURUS PicoPure Isolation Kit 452 
(ThermoFisher). The concentration of small quantities of RNA was determined using 453 
Nanodrop. Linear amplification of 10 ng of total RNA was performed using the Ovation Biotin 454 
RNA amplification and labelling system (NuGEN). Fragmented, labelled cDNA was hybridized 455 
to Affymetrix U133 plus 2 arrays. 456 
Single cell RNA sequencing 457 
Sample processing: all samples were processed within one hour from venipuncture. 458 
Cell Sorting: PBMCs were isolated from fresh whole blood using Ficoll-Paque Plus (GE) 459 
density gradient centrifugation. For cell sorting, we used fluorochrome-labeled antibodies 460 
specific for CD3 (UCHT1), CD27 (M-T271) (Biolegend), CD4 (RPA-T4), CD19 (HIB19), IgD 461 
(IA6-2), CD127 (HIL-7R-M21) (BD Biosciences), and CD8 (SCF121Thy2D3) (Beckman-462 
Coulter). CD8+IL7R+ (CD8+CD127+) and CD8+IL7R- (CD8+CD127-) T cells were sorted from 463 
the CD19-CD3+CD4- fraction. Cell sorting was performed using FACSAria Fusion (BD).  464 
Blood preparation for single cell RNA sequencing (scRNA-seq): PBMCs were thawed 465 
quickly at 37oC and transferred to DMEM supplemented with 10% FBS. Cells were spun down 466 
at 400 g, for 10 min. Cells were washed once with 1 x PBS supplemented with 0.04% BSA 467 
and finally re-suspended in 1 x PBS with 0.04% BSA. Viability was determined using trypan 468 
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blue staining and measured on a Countess FLII and samples with <80% viability were 469 
discarded. 12,000 cells were loaded for capture onto the Chromium System using the v2 single 470 
cell reagent kit (10X Genomics). Following capture and lysis, cDNA was synthesized and 471 
amplified (12 cycles) as per manufacturer's protocol (10X Genomics). The amplified cDNA 472 
was used to construct an Illumina sequencing library and sequenced on a single lane of a 473 
HiSeq 4000. 474 
Single cell Raw data processing and data combination: Illumina basecall files (*.bcl) were 475 
converted to fastqs using cellranger v2.1.0, which uses bcl2fastq v2.17.1.14. FASTQ files 476 
were then aligned to hg19 genome and transcriptome using the cellranger v2.1.0 pipeline, 477 
which generates a gene - cell expression matrix. The samples were merged together using 478 
cellranger aggr from cellranger, which aggregates outputs from multiple runs, normalizing 479 
them to the same sequencing depth (normalize=mapped) and then re-computing the gene-480 
barcode matrices and analysis on the combined data (See scripts here: 481 
https://github.com/dnehar/Temra-IL7R-Senescence).  482 
Scrublet for multiplet prediction and removal: Generally, we expected about 2 to 8% of 483 
the cells to be hybrid transcriptomes or multiplets, occurring when two or more cells are 484 
captured within the same microfluidic droplet and are tagged with the same barcode. Such 485 
artifactual multiplets can confound downstream analyses. We applied Scrublet44 python 486 
package to remove the putative multiplets. Scrublet assigns each measured transcriptome a 487 
‘multiplet score’, which indicates the probability of being a hybrid transcriptome. Multiplet 488 
scores were determined for each individual (using the raw data), and 0.7% - 10.7% highest 489 
scoring cells were tagged as multiplets after visual inspection of doublet score distributions 490 
and excluded from the further analysis.  491 
Single cell processing, clustering and cell type classification: The aggregated matrices 492 
were fed into the Python-based ScanPy45 workflow (https://scanpy.readthedocs.io/en/stable/), 493 
which includes preprocessing, visualization, clustering and differential expression testing. The 494 
pipeline we used was inspired by The Seurat46 R package workflow. 495 
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Quality control and cell-filtering: We applied the following filtering parameters: (i) all genes 496 
that were not detected in ≥ 3 cells were discarded, (ii) cells with less than 400 total unique 497 
transcripts were removed prior to downstream analysis, (iii) cells in which > 20% of the 498 
transcripts mapped to the mitochondrial genes were filtered out, as this can be a marker of 499 
poor-quality cells and (iv) cells displaying a unique gene counts > 2,500 genes were 500 
considered outliers and discarded. 501 
Data normalization: After discarding unwanted cells from the dataset, we normalized the 502 
data. Library-size normalization was performed based on gene expression for each barcode 503 
by scaling the total number of transcripts per cell to 10,000. We log-transformed the data and 504 
then regressed out using the total number of genes and the fraction of mitochondrial transcript 505 
content per cell. 1202 highly variable genes (HVG) were identified using 506 
filter_genes_dispersion scanpy function and used to perform the principal component analysis 507 
(PCA). 508 
Linear dimensional reduction using PCA and graph-based clustering: Dimensionality 509 
reduction was carried out in SCANPY via principal component analysis followed by Louvain 510 
clustering UMAP visualization using the top 40 significant components (PCs)47. 511 
Finding marker genes/evaluation of cluster identity: To annotate the cell type of each 512 
single cell transcriptome, we used both differential expression analysis between clusters and 513 
classification based on putative marker gene expression. We applied the 514 
‘tl.rank_genes_groups’ scanpy function to perform differential analyses, comparing each 515 
cluster to the rest of the cell using Wilcoxon test (Supplementary Table 3). We only considerate 516 
clusters that showed a distinct trancriptomic programs. 517 
Batch effect correction: We performed a batch (10X genomics batch) correction using 518 
BBKNN (https://github.com/Teichlab/bbknn)48. More details about the parameters used can 519 
be found as a Jupyter notebook here: https://github.com/dnehar/Temra-IL7R-Senescence. 520 
NK and Senescence scores:  521 
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Gene lists (Table S3) were used to score NK or senescence expression in naïve and Temras 522 
CD8 T cells. To do so, we calculated the mean expression for each cell, within each cluster 523 
using the h5ad object (adata), as follow:  524 
adata.obs['NK_score] = adata.X[:,NK_markers].mean(1). 525 
The scores were then plotted, as shown in Fig .3D.  526 
Lentiviral transduction 527 
Sestrin knockdown in human CD8+ T cells was achieved using a lentiviral transduction system 528 
as described previously9. 529 
The pHIV1-SIREN-GFP system used for knockdown of gene expression possesses a U6-530 
shRNA cassette to drive shRNA expression and a GFP reporter gene that is controlled by a 531 
PGK promoter5. The following siRNA sequences were used for gene knockdowns: 532 
CCTAAGGTTAAGTCGCCCTCG (shCTRL), CCAGGACCAATGGTAGACAAA (shSesn1), 533 
CCGAAGAATGTACAACCTCTT (shSesn2) and CAGTTCTCTAGTGTCAAAGTT (shSesn3). 534 
VSV-g pseudotyped lentiviral particles were produced, concentrated and titrated in HEK293 535 
cells as described9. 536 
Cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated FCS, 100 537 
U/ml penicillin, 100 mg/ml streptomycin, 50 μg/ml gentamicin, 2 mM L-glutamine (all from 538 
Invitrogen) and 0.5 ng/ml anti-mycoplasma (Bio-Rad) at 37 °C in a humidified 5% CO2 539 
incubator. Purified human highly differentiated CD28−CD8+ T cells were activated in the 540 
presence of plate-bound anti-CD3 (purified OKT3, 0.5 μg/ml) plus rhIL-2 (R&D Systems, 10 541 
ng/ml), and then transduced with pHIV1-Siren lentiviral particles (multiplicity of infection (MOI) 542 
= 10) 72 h after activation. 543 
Flow cytometry and phospho-flow 544 
Multi-parameter flow cytometry was used for phenotypic and functional analyses of PBMC. 545 
For analysis of surface markers, staining was performed at 4°C for 30 min in the presence of 546 
saturating concentrations of antibodies (listed in Supplementary table 5) and a live/dead 547 
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fixable Near-Infrared stain (Thermo Scientific, L10119). For intracellular analysis of cytokine 548 
secretion, cytotoxic granule expression, and sestrin 1, sestrin 2, DAP12, and DAP10 549 
expression, cells were fixed and permeabilized with the Fix & Perm® Kit (Invitrogen, Life 550 
Technologies, UK), before incubation with indicated antibodies or the respective isotype 551 
controls. For imaging cytometry, samples were acquired on an Amnis ImageStreamX Mk2 552 
using INSPIRE software, magnification 60X. Data were analysed using IDEAS v6.2 software 553 
(Amnis). Co-localization of signals was determined on a single cell basis using bright detail 554 
similarity (BDS) score analysis. Co-localization was considered with BDS ≥ 2.0. 555 
For Phospho-Flow cytometry, after staining for surface markers, CD8+ T cells were stimulated 556 
with anti-CD3 (purified OKT3, 10 μg/mL) for 30 minutes on ice, followed by crosslinking with 557 
goat anti–mouse IgG antibody during 30 minutes on ice. Cells were then transferred to an 558 
incubator at 37°C, and stimulation was terminated after 10 minutes, with immediate fixation 559 
with Cytofix Buffer (PBS containing 4% paraformaldehyde, BD Biosciences) followed by 560 
permeabilization with ice-cold Perm Buffer III (PBS containing 90% methanol, BD 561 
Biosciences) and staining with antibodies for phospho-proteins (listed in Table 2) for 30 562 
minutes at room temperature. Samples were acquired on a LSR II flow cytometer (BD 563 
Biosciences) and analysed using FlowJo software (TreeStar). 564 
Cytotoxic assays - CD107a degranulation assay 565 
Freshly isolated NK and CD8+ T cell subsets were incubated at 37°C for 6 h with K562 or C1R-566 
MICA/C1R cells, at a fixed effector to target (E:T) ratio of 2:1, in the presence of APC-567 
conjugated CD107a antibody (BD Biosciences), as previously described68. Brefeldin A 568 
(1μg/ml; Sigma-Aldrich) and Monensin (1 μg/ml; Sigma-Aldrich) were added in the final 5h-569 
incubation period. Effector cells incubated alone in the presence phorbol-12-myristate-13-570 
acetate (PMA, 50 ng/ml, Sigma-Aldrich) with ionomycin, (250 ng/ml, Sigma-Aldrich) were used 571 
as positive control whereas medium alone served as unstimulated (US) control. After 572 
incubation, cells were stained for surface markers for 30 min on ice, followed by intracellular 573 
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detection of cytokines (TNF-α and IFN-γ) and CD107a expression and analysed by flow 574 
cytometry. 575 
Cell lines 576 
K562 (human erythroleukemic) cell line was purchased from the European Collection of Cell 577 
cultures (ECCAC, UK) and cultured in 25 cm2 flasks (Nunc) in complete RPMI-1640. B-578 
lymphoblastoid cell lines, C1R and C1R transfected with MICA*008 (C1RMICA) were kindly 579 
provided by Professor Antoine Toubert (INSERM UMR1160, Paris) and maintained in 580 
complete RPMI-1640 in the presence of the aminoglycoside antibiotic G-418 (Sigma, G8168) 581 
for selection of transfected cells49. 582 
Immunoblotting 583 
Human CD8+ T cell subsets purified using immunomagnetic separation (MACS) according to 584 
CD27/CD28 expression were stimulated with anti-CD3 (purified OKT3, 10 μg/mL) or anti-585 
NKG2D (1D11, 10 μg/mL) before lysis. Cells were normalized by equal cell number, harvested 586 
and lysed in ice-cold Radio-Immunoprecipitation Assay (RIPA) buffer (Sigma-Aldrich, UK), 587 
supplemented with protease and phosphatase inhibitors (GE Healthcare, Amersham, UK), 588 
during 30 minutes on ice. Cell lysates were processed for immunoblot analysis as described6.  589 
Immunoprecipitation 590 
Human CD8+ T cells were separated into CD28+/CD28- fractions (to obtain sufficient number 591 
of cells for analysis) and stimulated with anti-NKG2D (1D11, 10 μg/mL) or isotype control, for 592 
30 minutes at 4 °C. Lysates from 1x107 cells were prepared with ice-cold HNGT buffer (50 593 
mM HEPES, pH 7.5, 150 mM EDTA, 10 mM sodium pyrophosphate, 100 mM sodium 594 
orthovanadate, 100 mM sodium fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 1 mM 595 
phenylmethylsulfonyl fluoride), for 30 minutes on ice. Cell lysates were incubated overnight at 596 
4°C with anti-NKG2D antibody (clone 5C6, Santa Cruz) or control antibody, followed by 597 
precipitation with 10 μL of pre-washed protein A/G agarose beads (sc-2003, Santa Cruz) for 598 
3 h at 4°C on a rotary shaker. After extensive washing in HGNT buffer, supernatants were 599 
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recovered and processed for immunoblot analysis, as described above. Co- 600 
Immunoprecipitated proteins were detected after incubation with primary antibodies followed 601 
by incubation with mouse anti-rabbit IgG (conformation-specific antibody; L27A9; Cell 602 
Signaling) or mouse anti-rabbit IgG light chain (L57A3; Cell Signaling) and by a secondary 603 
anti-mouse IgG antibody (7076; Cell Signaling). 604 
Mice 605 
Sesn1-/- and Sesn2-/- mice were described previously7. The mouse ageing study was 606 
performed at the University of Michigan, where the animal procedures were approved by the 607 
Institutional Animal Care & Use Committee and overseen by the Unit for Laboratory Animal 608 
Medicine. All mice were rested for at least 10 days before being used for in vivo studies. 609 
Animals were housed under standard conditions, maintained in a 12 h/12 h light/dark cycle at 610 
22 oC ± 1 oC and given food and tap water ad libitum in accordance with United Kingdom 611 
Home Office regulations (PPL-P69E3D849) and the NIH guideline. 612 
Murine delayed type hypersensitivity model 613 
Knockout and age-matched (18-month-old) C57BL66J WT control mice were imported from 614 
the University of Michigan. Young (~6 weeks) WT mice were purchased separately from 615 
Charles River. All mice were male. The methylated BSA (mBSA) delayed type hypersensitivity 616 
model was performed as described previously50. Mice were sensitized at the base of the tail 617 
with a 50 µl injection of mBSA in Freund’s complete adjuvant (20 mg/ml solution of mBSA in 618 
saline emulsified with an equal volume of Freund’s adjuvant containing 4 mg/ml 619 
Mycobacterium tuberculosis H37Ra, Sigma Aldrich). An immune response was evoked 14 620 
days later by subplantar challenge with 50 µl of mBSA in saline (1 mg/ml). The contralateral 621 
paw received a saline-only injection and served as a control. The immune response is reported 622 
as the difference in paw swelling between left and right paws as determined using callipers 623 
(POCO2, Kroeplin). Mice were sacrificed 7 days post-challenge, according to Schedule 1, 624 
using an increasing concentration of CO2. Death was confirmed by cervical dislocation. 625 
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Spleens and inguinal lymph nodes were obtained, weighed and dispersed through a 70 µm 626 
followed by a 35 µm sterile cell sieve (Becton Dickinson) to yield single cell suspensions. Cell 627 
numbers were enumerated by haemocytometer and up to 106 cells were used for 628 
polychromatic flow cytometry. 629 
In vivo cytotoxicity 630 
24-month-old knockout (Sesn1-/-Sesn2-/-Sesn3+/-) males were imported from the University of 631 
Michigan. Age-matched wild type female C57Bl/6J mice were purchased from Envigo. Natural 632 
killer cells were depleted by intraperitoneal injection of 100 μg anti-NK1.1 antibody (PK136, 633 
BioXCell) 24 hours before cell challenge. The high Rae-1 expressing myeloma cell line 5TGM 634 
was labeled with 5 μM CFSE, while splenocytes stained with 0.5 μM were used as Rae-1- 635 
controls. Both cell types were mixed at equal ratios and 2x107 were co-injected i.v. Mice were 636 
left for 6 hours before being sacrificed. As a measure of Rae-1 directed killing, the ratio of 637 
CFSEhi compared to CFSElo was used to determine Rae-1+ cell retrieval and specific lysis. 638 
Statistical analysis 639 
Statistical analysis was performed using GraphPad Prism version 6.00. Tests were used to 640 
determine data distribution and depending on the normality of the data, comparisons were 641 
performed using the Student t test (for two groups, parametric) or the non-parametric Mann–642 
Whitney U test (for two groups, unpaired) and the Wilcoxon signed rank test (for two groups, 643 
paired) with two-tailed P values unless otherwise stated. When comparing more than two 644 
groups, we used one-way ANOVA (parametric, > 2 groups, unpaired), repeated measures 645 
ANOVA (parametric, > 2 groups, paired), Kruskal–Wallis (non-parametric, > 2 groups, 646 
unpaired) or Friedman (non-parametric, > 2 groups, paired) tests with post-correction for 647 
multiple comparisons, as appropriate. The two-way ANOVA test was used to compare the 648 
effects of two independent variables between groups. Linear regression analysis was 649 
performed to generate lines of best fit and correlations between variables were analysed using 650 
Pearson´s or Spearman’s rank correlation coefficient (r). Differences were considered 651 
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significant when p <0.05 (*), p <0.01 (**), p <0.001(***) and p <0.0001 (****). Data are 652 
presented as means ± standard error of the mean (SEM) unless otherwise stated. 653 
Data and materials availability 654 
The data that support the findings of this study are available from the corresponding author 655 
upon request. The complete microarray dataset is available online from the NCBI Gene 656 
Expression Omnibus public repository (GEO accession number GSE98640). 657 
The single cell RNA-seq data are available on EGA (Accession number EGAS00001004255). 658 
 659 
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Figure legends 786 
Fig. 1: Transcriptional signature of human CD8+ T cell subsets 787 
a) Representative image of CD8+ T cells gated on CD27+CD45RA+ TN cell, CD27+CD45RA-788 
TCM cells, CD27-CD45RA-TEM cells, and CD27-CD45RA+TEMRA cells isolated from the PBMCs 789 
from 6 healthy donors. Numbers in gates represent percentages of cells in each subset from 790 
a representative donor. Similar results were obtained in other experiments. b) Heat map of 791 
gene expression of Affymetrix U133 plus 2 microarrays of sorted TN and TEMRA CD8+ T cell 792 
subsets, showing downregulated (in yellow) and upregulated genes (in blue). c) The relative 793 
fold-change (log10) of differentially expressed genes of interest in TCM, TEM and TEMRA CD8+ T 794 
cell subsets compared to TN CD8+ T cells. The list of genes of interest is shown in 795 
Supplementary table 2 and the complete list of differentially expressed genes from the whole-796 
transcriptome analysis (≥2-fold change, p<0.05, FDR<0.05%) is available in Supplementary 797 
table 1. d) NKR expression TN, TCM, TEM, and TEMRA CD8+ T cells assessed by flow cytometry 798 
on PBMCs from 22 healthy donors (median age = 52, range 25-83). e) Representative 799 
immunoblots of proximal TCR components Lck, PLCγ1, LAT and Zap70 on CD27+CD28+, 800 
CD27+CD28- and CD27-CD28- CD8+ T cells freshly isolated from PBMCs using magnetic 801 
activated cell. Similar data were obtained in 4 independent experiments. Summary data (n = 802 
4) of Lck, Zap70, PLCγ1 and LAT expression normalized to the loading control (GAPDH) and 803 
presented relative to the basal expression in CD27+28+CD8+ cells set to 1. d) Two-way 804 
ANOVA with Dunnett’s post-test correction and e) one-way ANOVA with Tukey’s correction 805 
(*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). 806 
Fig. 2: Single cell RNA-seq (scRNA-seq) of TN and TEMRA CD8+ T cells 807 
a) UMAP visualisation with clusters demarcated by colours identifying 13 CD8+ T cell clusters 808 
(C0 to C12)  from RNA-seq analysis of single-cell sorted IL-7R+CD8+ (n = 37,192 single cells) 809 
and IL-7R-CD8+ (n = 25,151 single cells) T cells from six healthy older donors. b) UMAP plot 810 
from a) pseudo-coloured to show clustering of IL7-R+ (in green) and IL7-R- (in purple) CD8+ T 811 
cells as identified during sorting. c) UMAP plot from a) representing expression values of 812 
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selected individual genes. Scales show low expression (yellow) to high expression (red). Other 813 
aliases or CD numbers of proteins encoded by the listed genes are shown in brackets. 814 
Fig. 3: NK and senescence markers within TN and TEMRA 815 
a) UMAP plot of single-cell sorted IL-7R+CD8+ and IL-7R-CD8+ T cells from six healthy older 816 
donors. Highlighted clusters were considered as TN (C0, C4 and C8) and TEMRA (C1, C2 and 817 
C6) compartments. b) UMAP plot showing re-clustering of selected TN (C0, C4, and C8) and 818 
TEMRA (C1, C2, and C6) CD8+ cells from a) (n = 39,634 cells). c) UMAP plots representing the 819 
expression values of NK-related genes in re-clustered TN and TEMRA CD8+ cells from b). Scales 820 
show low expression (yellow) to high expression (red). d) Violin plots of NK-related gene 821 
expression determined by scRNA-seq in TN and TEMRA CD8+ T cells clustered as in b) (means, 822 
range, and distribution of individual data; n = 39,364 single cells). e) UMAP plots showing 823 
expression of senescence-associated determined by scRNA-seq in TN and TEMRA CD8+ T cells 824 
re-clustered as in b). Scales show low expression (yellow) to high expression (red). Other 825 
aliases or CD numbers of some gene products are shown in brackets. f) Violin plots of 826 
senescence scores calculated based on the average normalized expression of each 827 
senescence-associated gene across TN and TEMRA CD8+ cells clustered as in b) (means, 828 
range, and distribution of individual data; n = 39,364 single cells). The gene lists used to define 829 
NK- and senescence-scores are given in Supplementary table 4). 830 
Fig. 4: NKG2D-DAP12 complex mediates NK cytotoxicity in CD27-CD28-CD8+ T cells 831 
a) Box-and-whisker plot of cell-surface CD107a expression of CD27+CD28+CD8+, 832 
CD27+CD28-CD8+, CD27-CD28-CD8+, and CD3-CD56+ NK cells isolated from healthy donors 833 
co-cultured with K562 cells at E:T 2:1 (median and range, n = 5). b) CD107a expression on 834 
CD28-CD8+ T cells transfected with NKG2D siRNA (siNKG2D) or control siRNA (siCtrl) and 835 
cultured with C1R-MICA or C1R (E:T ratio 2:1) for 6 hours (mean and s.e.m., n = 4). c) 836 
Immunoblots (representative of five independent experiments with similar results) and d) flow 837 
cytometry (means and s.e.m., n = 12) showing DAP12 expression on CD27+CD28+CD8+, 838 
CD27+CD28-CD8+, CD27-CD28-CD8+, and CD3-CD56+ NK cells. g) Expression of DAP12 in 839 
lysed CD28+CD8+ T cells and CD28-CD8+ T cells co-immunoprecipitated with antibody against 840 
NKG2D. Loading control, light-chain IgG (IgGL). Whole-cell lysate immunoblot shown as a 841 
control. Representative of two independent experiments. f) Phosphorylation of Zap70(Tyr319) 842 
and Syk(Tyr352) in freshly isolated CD27-CD28-CD8+ T cells after treated with CD3 mAb 843 
(OKT3, 10 μg/mL, 15 minutes) and/or NKG2D Ab (1D11, 5 μg/mL, 15 minutes). Numbers 844 
indicate relative expression normalized to total Zap70. Representative of 2 experiments. g) 845 
Granzyme B expression (left) and IFN-γ secretion (right) in CD27+CD28+CD8+, CD27+CD28-846 
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CD8+, and CD27-CD28-CD8+ T cells after stimulation with NKG2D Ab (5 μg/mL, means and 847 
s.e.m., n = 15 donors). h) CD107a expression in human CD28-CD8+ T cells transfected with 848 
DAP12 siRNA (siDAP12) or control siRNA (siCtrl) cultured with C1R-MICA*008 or C1R cells 849 
for 6 hours (E:T ratio 2:1; means and s.e.m., n = 4). Statistical significance determined with 850 
Kruskal-Wallis test in a) Friedman test with Dunn´s correction in d), two-way ANOVA with 851 
Bonferroni correction in b, j) and one-way ANOVA with Tukey’s in g) (*p <0.05, **p <0.01, ***p 852 
<0.001). 853 
Fig. 5: Sestrins and Jnk MAPK dampen TCR signalling in CD27-CD28-CD8+ T cells 854 
a) Representative histograms of P-CD3ζ in CD27+CD28+CD8+, CD27+CD28-CD8+, and CD27-855 
CD28-CD8+ T cells stimulated with anti-CD3 (OKT3, 10 μg/mL, 15 minutes). Unstimulated 856 
CD27+CD28+CD8+ are shown as a control. Numbers on histograms represent the mean 857 
fluorescence intensity (MFI) for each subset. Summary data are given (means and s.d., n = 8 858 
donors). b) Representative histograms of P-Zap70-Syk in CD27+CD28+CD8+, CD27+CD28-859 
CD8+, and CD27-CD28-CD8+ T cells stimulated as in a). Unstimulated CD27+CD28+CD8+ are 860 
shown as a control. Numbers on histograms represent the mean fluorescence intensity (MFI) 861 
for each subset. Summary data are given (means and s.d., n = 8). Summary results presented 862 
as the MFI relative to that of DP CD8+ T cells, set to 1. c, d) Expression of Sesn1 c) and Sesn2 863 
d) proteins determined by flow cytometry in CD27+CD28+CD8+, CD27+CD28-CD8+, and CD27-864 
CD28-CD8+ T cells (means and s.d., n = 10 donors). e) Immunoblot of Sesn2 and p-Jnk 865 
(T183/Y185) in CD27+CD28+CD8+, CD27+CD28-CD8+, and CD27-CD28-CD8+ T cells, freshly 866 
isolated from peripheral blood of healthy donors. Representative of three independent 867 
experiments with similar results. Densitometry data from western blots for all donors is also 868 
shown (means and s.e.m., n = 3 donors for p-Jnk, n = 4 donors for Sesn2). Statistical 869 
significance determined with ANOVA with Friedman test and Dunn’s post-test correction in a-870 
b), repeated measures one-way ANOVA with Tukey’s multiple comparisons test in c-e) (*p 871 
<0.05, **p <0.01, ***p <0.001, ****p <0.0001). 872 
Fig. 6: Sestrins regulate DAP12 and NKG2D expression in CD8+ T cells. 873 
a) Expression of DAP12, sestrin 2 and p-Jnk (T183/Y185) in lysed CD28+CD8+ T cells and 874 
CD28-CD8+ T cells immunoprecipitated with NKG2D. Loading control: IgG light chain (IgGL). 875 
Results are representative of two independent experiments. b) Cellular localization of Sesn2 876 
(AF488, green), DAP12 (PE, red) and P-Jnk (T183/Y185, AF647, yellow) in CD27+CD28+CD8+ 877 
and CD27-CD28-CD8+ T cells. “Sesn2”, “DAP12”, and “p-Jnk” denote single stain controls in 878 
CD27-CD28-CD8+. Nuclei are stained with DAPI (blue). Scale bars – 7 µm. c) Overlap of Sesn2 879 
and DAP12 or P-Jnk in CD27+CD28+CD8+ and CD27-CD28-CD8+ T cells. Bright detail 880 
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similarity scores exceeding 2 were considered to be overlapping. Data are normalized to the 881 
CD27+CD28+CD8+ T cell subset for each donor (means and s.d., n = 6). d-e) Isolated human 882 
CD8+CD28- T cells were transduced with control (shCtrl) or anti-sestrin (shSesn) vectors. d) 883 
Representative immunoblot for Sesn2 and DAP12 (representative of two experiments). e) 884 
Representative contour plots and summary data of NKG2D expression. Results are presented 885 
relative to cells transduced with shCtrl for each donor, set as 1 (means and s.d., n = 3 donors). 886 
f) Frequency of NKG2D and CD28 in isolated CD28-CD8+ T treated with siJnk (means and 887 
s.d., n = 6 donors). g) Lck phosphorylation in CD28-CD8+ T cells pre-treated with Jnk inhibitor 888 
(SP-600125, 10 µM) prior to anti-CD3 stimulation (OKT3, 10 µg/ml, 15 minutes; means and 889 
s.d., n = 8 donors). Two-tailed paired Student’s t tests in c,f-g) (*p <0.05, **p <0.01, ***p 890 
<0.001). 891 
Fig. 7: Sestrins induce an age-dependent NK phenotype in CD8+ T cells in vivo 892 
a) Measurement of paw size (normalized to the contralateral, PBS control paw) over time (0h, 893 
4h, 24h, 36h, 2, 3, 4, 5, 6, 7 days) in young wild-type (young WT; n = 4), old WT (n = 10), old 894 
Sesn1-/- (n = 5) and old Sesn2-/- (n = 4) mice following intra-plantar treatment with mBSA. b) 895 
Area under the curve integration of the time course data shown in a) (means and s.d.) c) 896 
Representative pseudo-colour density plots showing CD44 vs NKG2D expression on 897 
TCRβ+CD3+CD8+ T cells isolated from spleens of young WT, old WT,  old Sesn1-/-, and old 898 
Sesn2-/- mice. Frequencies of parent gates are shown in the top right-hand corner. d) 899 
Cumulative data of NKG2D expression in splenic TCRβ+CD3+CD8+ T cells from young WT, 900 
old WT, old Sesn1-/-, and old Sesn2-/- mice (n = 3 mice per group). e) Representative histogram 901 
of DAP12 expression from splenic TCRβ+CD3+CD8+ T cells from young WT, old WT, old 902 
Sesn1-/-, and old Sesn2-/- mice. FMO control is shown. Cumulative data shown (n = 3 per 903 
group, n = 1 young WT). f) NKG2D expression in splenic NK- and iNKT cells from the same 904 
mice as in c-d) (means and s.d., n = 3 mice per group). g) Retrieval of Rae-1+ 5TGM1 cells 905 
as a fraction of injected cells (left panel) and killing and specific lysis of injected Rae-1+ 5TGM1 906 
cells (right panel) from the spleens of NK-depleted (24h, anti-NK1.1, i.p.) old WT and old 907 
Sesn1-/-Sesn2-/-Sesn3+/- mice 6 hours after i.v. challenge (means and s.d., n = 3 mice per 908 
group). Statistical significance determined with one-way ANOVA with Tukey’s multiple 909 
comparisons test in b,d-g); two-tailed unpaired Student’s t tests in h-i). (*p <0.05, **p <0.01, 910 
***p <0.001, ****p <0.0001). 911 
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